Anura Indulkar

1. Introduction Click to copy section linkSection link copied! As biological targets grow increasingly complex, drug discovery efforts are progressively generating structurally intricate molecules that often fall outside the traditional drug-like chemical space originally defined by Lipinski’s Rule of Five. (1,2) Among these emerging drug modalities, proteolysis-targeting chimeras (PROTACs) have garnered significant attention.